Karl Chalabala
Stock Analyst at UBS
(2.01)
# 2,889
Out of 4,671 analysts
5
Total ratings
60%
Success rate
2.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Karl Chalabala
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FOLD Amicus Therapeutics | Maintains: Buy | $20 → $19 | $9.66 | +96.69% | 2 | May 10, 2024 | |
SCCO Southern Copper | Maintains: Sell | $47 → $50 | $99.74 | -49.97% | 1 | Feb 23, 2023 | |
CRK Comstock Resources | Maintains: Buy | $14 → $12 | $15.16 | -20.84% | 1 | Aug 14, 2017 | |
GPOR Gulfport Energy | Maintains: Buy | $21 → $18 | $176.77 | -89.82% | 1 | Aug 14, 2017 |
Amicus Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $20 → $19
Current: $9.66
Upside: +96.69%
Southern Copper
Feb 23, 2023
Maintains: Sell
Price Target: $47 → $50
Current: $99.74
Upside: -49.97%
Comstock Resources
Aug 14, 2017
Maintains: Buy
Price Target: $14 → $12
Current: $15.16
Upside: -20.84%
Gulfport Energy
Aug 14, 2017
Maintains: Buy
Price Target: $21 → $18
Current: $176.77
Upside: -89.82%